立即開始
mazdaki

CERS- There is substantial Market for PI Platelets

看多
Cerus Corporation (NASDAQ:CERS)  
mazdaki  
NASDAQ:CERS   Cerus Corporation
0
2
with serial FDA approvals, there will be institutional buyers accumulating this stock. Started an initial position and will add on weakness.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。